Pharmaceutical Business Review

AUGUST 28, 2023

These candidates are being developed to offer better protection, extend the duration in preventing illness and transmission, as compared to the current vaccine technologies. As part of the contract, Allucent will initiate a Phase IIb clinical trial of 10,000 participants under BARDA’s Clinical Studies Network.

Vaccines 52

Vaccines Clinical Pharmacology Immunity Immunization 52

pharmaphorum

NOVEMBER 4, 2020

The picture is hardly more promising for vaccines: the number of approaches, difficulty in finding patients in which to carry out pivotal trials, irrelevant choice of endpoints … the outlook is far from promising. The M&S approach should be integrative, from the molecular level to the clinical and population outcomes.

Vaccines 105

Vaccines Clinical Pharmacology Immunity Immunization 105

Pharmaceutical Technology

DECEMBER 16, 2022

Novel therapeutics and vaccines for malaria. This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology. Pyramax was codeveloped by MMV and the South Korean company Shin Poong.

Drug Development 105

Drug Development Vaccines Clinical Pharmacology Compounding 105